2018 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-19±³À°ÀÏÀÚ : 2018-10-19
±³À°Àå¼Ò : The-K È£ÅÚ º»°ü 3Ãþ, °Å¹®°íȦ
±³À°ÁÖÁ¦ :
2018 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
kspho@kams.or.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 10:30~11:30 MYCN ÁõÆø ¾ç¼ºÀΠȯÀÚ±º¿¡¼ neurotophin3 ¹ßÇöÀÇ ÀÓ»óÀû ÀÇÀÇ ¼Àº¼·(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 11:30~12:30 Epidemiology of carcinomas in adolescents and young adults: a nationwide population-based study in Korea 2011-2015 °Áö¸¸(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 13:40~14:10 Epidemiology of PID in Korea ±è¿¹Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 14:10~14:40 HSCT for Primary Immunodeficiency in Japan Kohsuke Imai(Tokyo Medical and Dental University)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 14:40~15:10 HSCT for PID in Korea ¹éÈñÁ¶(Àü³²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 15:10~15:40 HSCT in patients with STAT1 gain-of-function mutation Satoshi Okada(Hiroshima University)
±³À°½Ã°£ 10¿ù 19ÀÏ °Å¹®°íȦ 16:20~17:00 What shoud be the preferred approach to children with aplastic anemia : : IST vs. BMT Michael Pulsipher(Children¡¯s Hospital Los Angeles)
±³À°½Ã°£ 10¿ù 19ÀÏ 17:00~17:10 °Ç°Àå¾ÖÇлýÀ» À§ÇÑ ±³À°Áö¿ø Á¤Ã¥ ¾È³» ¹é¼öÁø(±³À°ºÎ)
±³À°½Ã°£ 10¿ù 19ÀÏ 17:10~17:20 ¼Ò¾Æû¼Ò³â¾Ï »ýÁ¸ÀÚ °ü¸® ¹æÇâ : Á¤Ã¥ Á᫐ ±è¿µ¾Ö(±¹¸³¾Ï¼¾Å¸)
±³À°½Ã°£ 10¿ù 19ÀÏ 17:20~17:35 ¼Ò¾Æû¼Ò³â ¿ÏÈÀÇ·á ½Ã¹ü»ç¾÷ ¾È³» ÀåÀ±Á¤(Áß¾ÓÈ£½ºÇǽº¼¾ÅÍ)
±³À°½Ã°£ 10¿ù 19ÀÏ 17:35~17:50 ¼Ò¾Æû¼Ò³â ¿ÏÈÀÇ·áÀÇ ½ÇÁ¦ ±è¹Î¼±(¼¿ïÀÇ´ë)